Evidence map›Paper›PMID 32817904›Full record

ArticleContemporary clinical trials communications2020

More than a box to check: Research sponsor and clinical investigator perspectives on making GCP training relevant.

Teresa Swezey, F Hunter McGuire, Patricia Hurley, Janette Panhuis, Kathy Goldstein, Tina Chuck, Carrie Dombeck, Brian Perry, Christina Brennan, Natasha Phrsai and 1 more

Abstract read
In one paragraph

Article in Contemporary clinical trials communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Teresa SwezeyClinical Trials Transformation Initiative, Duke University, Durham, NC, USA.
F Hunter McGuireClinical Trials Transformation Initiative, Duke University, Durham, NC, USA.
Patricia HurleyAmerican Society of Clinical Oncology, Alexandria, VA, USA.
Janette PanhuisPopulation Health Research Institute, Hamilton, ON, Canada.
Kathy GoldsteinRegeneron Pharmaceuticals, Tarrytown, NY, USA.
Tina ChuckThe Feinstein Institutes for Medical Research, Northwell Health, Great Neck, NY, USA.
Carrie DombeckClinical Trials Transformation Initiative, Duke University, Durham, NC, USA.
Brian PerryClinical Trials Transformation Initiative, Duke University, Durham, NC, USA.
Christina BrennanThe Feinstein Institutes for Medical Research, Northwell Health, Great Neck, NY, USA.
Natasha PhrsaiThe Feinstein Institutes for Medical Research, Northwell Health, Great Neck, NY, USA.
Amy CorneliClinical Trials Transformation Initiative, Duke University, Durham, NC, USA.

Funding

FDA HHS R18 FD005292FDA HHS U18 FD005292
6 · The paper itself

Abstract

backgroundGood clinical practice (GCP) training is the industry expectation for ensuring quality conduct of registrational clinical trials. However, concerns exist about whether the current structure and delivery of GCP training sufficiently prepares clinical investigators and their delegates to conduct clinical trials.

methodsWe conducted qualitative semi-structured interviews with 13 clinical investigators and 10 research sponsors to 1) examine characteristics of the quality conduct of sponsored clinical trials, including critical tasks and concerns perceived as essential for trial quality, 2) identify key knowledge and skills required to perform critical tasks, and 3) identify gaps and redundancies in GCP training and areas of improvement to ensure quality conduct of clinical trials. Data were examined using applied thematic analysis.

resultsThe top three tasks identified as critical for the quality conduct of clinical trials were obtaining informed consent, ensuring protocol compliance, and protecting participants' health and safety. Respondents acknowledged that GCP principles address each of these critical tasks but also described many challenges and burdens of GCP training, including high training frequency and repetitive content. Respondents suggested moving beyond GCP training as a mere check-box activity by making it more effective, engaging, and interactive. They also emphasized that applying GCP principles in a real-world, skills-based environment would increase the perceived relevance of GCP training.

conclusionOur findings indicate that although investigators and sponsors recognize that GCP training addresses tasks critical to the quality conduct of clinical trials, the need for significant improvement in the design, content, and presentation of GCP training remains.

Indexed as

Clinical investigatorClinical trialsGood clinical practiceInvestigator trainingQuality

Identifiers

PMID32817904
PMCPMC7426536

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.